Maurizio Martelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2024
Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in Chronic myeloid leukemia (CML)	EXPERT REVIEW OF HEMATOLOGY	2024
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results	JOURNAL OF CLINICAL ONCOLOGY	2024
Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma	HAEMATOLOGICA	2024
A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD	LEUKEMIA & LYMPHOMA	2024
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study	INFECTION AND DRUG RESISTANCE	2023
Late appearance of JAK2 mutated polycythaemia vera in a patient with typical chronic myeloid leukaemia on imatinib: Speculations about role of therapeutic pressure and of secondary genetic events	LEUKEMIA RESEARCH	2023
Whole body MRI with Difusion Weighted Imaging versus 18F‑fuorodeoxyglucose‑PET/CT in the staging of lymphomas	LA RADIOLOGIA MEDICA	2023
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia	CANCERS	2023
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas	LA RADIOLOGIA MEDICA	2023
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study	JOURNAL OF CLINICAL MEDICINE	2023
Case Report: Infectious prophylaxis in hematological malignancies	FRONTIERS IN ONCOLOGY	2023
Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients?	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2023
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel	HEMASPHERE	2023
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2023
Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients	ANNALS OF HEMATOLOGY	2023
Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination	FRONTIERS IN ONCOLOGY	2023
Asciminib as a third line option in chronic myeloid leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY	2023
Editorial: HBV and lymphoma	FRONTIERS IN ONCOLOGY	2023
CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases	LEUKEMIA & LYMPHOMA	2023